Skip to main content

Understanding compound selectivity with data-driven drug design

Selectivity is a crucial property in the development of new active pharmaceutical ingredients (APIs). Binding site comparisons within a protein family are key to modulating the selectivity profile of a potential new API, which includes understanding both on- and off-target effects. This white paper outlines the importance of data-driven-drug design to maximise compound selectivity.

Researchers at Oxford, Exscientia, and CCDC recently leveraged the hand-curated, experimentally derived data in the Cambridge Structural Database (CSD), the CCDC software suites CSD-Core and CSD-Discovery, and the CSD Python API to automate “ensemble hotspot maps,” which highlight conserved interactions and, potentially, selectivity pockets across multiple protein confirmations.

Ensemble hotspot maps summarize important fragment-binding interactions. Such information can guide computational workflows that allow researchers to rapidly explore the chemical space for lead compounds.



Premium Access

To access this content please enter your details in the fields below.

Media Partners